William B. Nelson, MD
Research Investigator and Director of the Cardiac Rehabilitation and Cardiovascular Research Programs at Regions Hospital
About

HealthPartners Medical Group title: Cardiologist and director of the Cardiac Rehabilitation and Cardiovascular Research programs at Regions Hospital

Education: MD, University of Minnesota Medical School; residency in internal medicine, University of Minnesota Medical Center; fellowship in cardiovascular disease, University of Wisconsin Hospital & Clinics; fellowship in nuclear medicine, University of Wisconsin Hospitals- Madison.
Affiliation
positions
  • Clinical Research Investigator, Cardiovascular health
  • Research Investigator, Critical Care Research Center
    • Publications While At HealthPartners
    selected publications
    Journal Article
  • Sex difference in mitral valve prolapse regurgitant volume is resolved by normalization of regurgitant volume to left ventricular end-diastolic volume. 
    International Journal of Cardiovascular Imaging. 2024
  • Gender differences in primary mitral regurgitant volumes at specific regurgitant fractions as assessed by magnetic resonance imaging. 
    International Journal of Cardiovascular Imaging. 2022
  • Inappropriate noise detection in Tendril family pacing leads. 
    Journal of Cardiovascular Electrophysiology. 2019
  • Prevalence and doppler echocardiographic characteristics of normally functioning mitral prostheses with mean gradient >/=10 mmHg. 
    Journal of Heart Valve Disease. 2017
  • Safety of continuing warfarin therapy in patients undergoing cardiac resynchronization therapy device implantation
    2017
  • Feasibility of an elective cardioversion service led by advanced practice providers without direct cardiologist supervision
    2016
  • Normalization of left ventricular ejection fraction and incidence of appropriate antitachycardia therapy in patients with implantable cardioverter defibrillator for primary prevention of sudden death. 
    Journal of Cardiac Failure. 2016
  • The association between cardiac rehabilitation attendance and hospital readmission. 
    American Journal of Lifestyle Medicine. 2016
  • Anatomic versus effective orifice area in a bicuspid aortic valve. 
    Echocardiography (Mount Kisco, N.Y.). 2014
  • Letter by House et al regarding article, "Prosthesis-patient mismatch in bovine pericardial aortic valves: evaluation using 3 different modalities and associated medium-term outcomes". 
    Circulation: Cardiovascular Imaging. 2014
  • Reply to comment on: "Anatomic versus effective orifice area in a bicuspid aortic valve". 
    Echocardiography (Mount Kisco, N.Y.). 2014
  • Ultra low-dose single photon emission computed tomography myocardial perfusion imaging
    2014
  • Bundle branch block re-entry ventricular tachycardia storm during the recovery phase of transient complete heart block
    2013
  • Aortic pseudoaneurysm in a patient with rheumatoid arthritis. 
    Texas Heart Institute Journal. 2011
  • Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients. 
    European Journal of Echocardiography. 2011
  • Chronic kidney disease is an independent predictor of pocket hematoma after pacemaker and defibrillator implantation. 
    Journal of Interventional Cardiac Electrophysiology. 2010
  • Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. 
    Heart rhythm. 2010
  • Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death. 
    Heart International. 2010
  • Acute coronary thrombosis in a patient with septic shock without any evidence of disseminated intravascular coagulation. 
    BMJ Case Reports. 2009
  • How reliable is an effective orifice area indexed chart?. 
    Journal of Heart Valve Disease. 2009
  • Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB). 
    Journal of Cardiothoracic Surgery. 2009
  • Sudden cardiac arrest in apical hypertrophic cardiomyopathy. 
    BMJ Case Reports. 2009
    • Editorial Article
  • Questions regarding a recent study comparing mitral regurgitant volume between proximal flow convergence and volumetric methods: the importance of sex differences [editorial]. 
    Journal of the American Society of Echocardiography.  35. 2022
    • Review
  • Manufacturer-provided effective orifice area index charts and the prevention of prosthesis-patient mismatch [review]. 
    Journal of Heart Valve Disease. 2012
  • Safety of coronary angiography and percutaneous coronary intervention in patients on uninterrupted warfarin therapy: a meta-analysis [review, meta-analysis]. 
    Interventional Cardiology. 2011
    • Abstract
  • A comparison of left ventricular volumes and ejection fraction by various commercially-available nuclear cardiology software on a CZT SPECT camera [abstract]. 
    Journal of Nuclear Cardiology. 2017
  • The incidence and doppler echocardiographic characteristics of normally functioning mitral prostheses with mean gradient ≥ 10 mm Hg [abstract]. 
    Journal of the American Society of Echocardiography. 2016
  • Early discharge with next day stress testing in low risk chest pain patients presenting to the emergency department is feasible [abstract]. 
    Annals of Emergency Medicine. 2015
  • Normalization of left ventricular ejection fraction is associated with the absence of appropriate anti-tachycardia therapy in patients receiving implantable defibrillators for the primary prevention of sudden death [abstract]. 
    Circulation. 2013
  • Normalization of left ventricular ejection fraction is associated with the absence of appropriate anti-tachycardia therapy in patients receiving implantable defibrillators for the primary prevention of sudden death [abstract]
    2013
  • High incidence of externalized conductors in St. Jude Medical Riata defibrillator leads: results of fluoroscopic surveillance from a single center in U.S. [abstract]. 
    Heart rhythm. 2012
  • The safety and efficacy of elective direct current cardioversion of atrial fibrillation and atrial flutter performed by advance practice providers [abstract]. 
    Heart rhythm. 2012
  • Ultra-low dose single photon emission computed tomography myocardial perfusion imaging [abstract]. 
    Journal of Nuclear Cardiology. 2012
  • Chronic kidney disease is a significant risk factor of pocket hematoma formation after pacemaker and implantable cardioverter-defibrillator placement independent of anticoagulation and antiplatelet agents [abstract]. 
    Journal of the American College of Cardiology. 2010
  • Metabolic syndrome predicts poor outcome in patients with systolic heart failure who received implantable-cardioverter defibrillator for primary prevention of sudden cardiac death [abstract]. 
    Heart rhythm. 2010
  • Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients [abstract]. 
    Journal of the American Society of Echocardiography. 2010
  • Continuation of warfarin is superior to holding warfarin with or without bridging therapy in patients undergoing pacemaker and defibrillator placement [abstract]. 
    Circulation. 2009
  • Safety of cardiac resynchronization therapy device implantation in patients with uninterrupted chronic warfarin therapy [abstract]. 
    Circulation. 2009
    • presentations
    Presentation
  • A comparison of three different peri-operative anticoagulation strategies during cardiac resynchronization therapy implantation [presentation]
  • Association and severity of coronary artery disease and carotid artery disease in patients with aortic stenosis [presentation]
  • Chronic kidney disease is a significant predictor of pocket hematoma complications after pacemaker and implantable cardioverter defibrillator placement independent of anticoagulation and antiplatelet agents [presentation]
  • Continuation of warfarin is superior to holding warfarin with or without bridging therapy in patients undergoing pacemaker and defibrillator placement [presentation]
  • How reliable is an effective orifice area indexed chart [presentation]?
  • Metabolic syndrome predicts poor outcome in patients with systolic heart failure who received implantable-cardioverter defibrillator for primary prevention of sudden cardiac death [presentation]
  • Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients [presentation]
  • Normalization of left ventricular ejection fraction is associated with the absence of appropriate anti-tachycardia therapy in patients receiving implantable defibrillators for the primary prevention of sudden death [presentation]
  • Predictors and prognosis of worsening renal function in patients hospitalized with acute diastolic heart failure and treated with intravenous furosemide [presentation]
  • Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB) [presentation]
  • Safety of cardiac resynchronization therapy device implantation in patients with uninterrupted chronic warfarin therapy [presentation]
  • Safety of coronary angiography and percutaneous coronary intervention in patients on uninterrupted warfarin therapy: a systematic review and meta-analysis [presentation]
  • The assessment of cardiac workload during simulated firefighting tasks [presentation]
  • The dose response of cardiac rehabilitation [presentation]
  • The implementation of cognitive function assessment during cardiac rehabilitation [presentation]
  • The incidence and doppler echocardiographic characteristics of normally functioning mitral prostheses with mean gradient ≥ 10 mm Hg [presentation]
  • The safety and efficacy of elective direct current cardioversion of atrial fibrillation and atrial flutter performed by advance practice providers [presentation]
  • Ultra-low dose single photon emission computed tomography myocardial perfusion imaging [presentation]
    • Contact
    full name
  • William B. Nelson, MD
    • located in facility
    Quick Info
     
    Collaboration
    More Info